The Therapeutic Dilemma of Hypertension in the Elderly Stevo Julius Section 1 18 October 2012 Pages: 7 - 17
Comparative Double-Blind Study of Ketanserin versus Propranolol in the Treatment of Essential Hypertension K. ItoT. OmaeK. Tanaka Section 1 18 October 2012 Pages: 18 - 24
Effects of Ketanserin Tartrate on Serum Lipids in Patients with Essential Hypertension H. NakamuraF. HirataI. Takeuchi Section 1 18 October 2012 Pages: 25 - 34
Ketanserin in the Treatment of Diabetes-Associated Hypertension Carlo Beretta-Piccoli Section 1 18 October 2012 Pages: 35 - 43
Interference of Ketanserin with Baroreflex Control of the Circulation in the Conscious Spontaneously Hypertensive Rat J. SmitsF. van DorstenH. A. J. Struyker Boudier Section 2 18 October 2012 Pages: 55 - 60
Serotonin Metabolism and Age-Related Effects of Antihypertensive Therapy with Ketanserin Ruth AmsteinNatalia FetkovskaFritz R. Bühler Section 2 18 October 2012 Pages: 61 - 66
The Relevance of Serotonin Antagonism in the Treatment of Hypertension A. E. Doyle Section 2 18 October 2012 Pages: 67 - 73
Arterial Dilatation and Venous Constriction Induced by Serotonin in the Elderly G. J. BlauwP. van BrummelenP. A. van Zwieten Short Communication 18 October 2012 Pages: 74 - 77
Serotonin and Platelet Aggregation in Patients with Essential Hypertension Compared with a Normotensive Control Group David J. StottAbbey R. SaniabadiStephen G. Ball Short Communication 18 October 2012 Pages: 78 - 82
Role of Endogenous Serotonin in the Regulation of Blood Pressure in Patients with Chronic Renal Failure Minoru YamakadoMasashi NaganoHiroshi Kiyose Short Communication 18 October 2012 Pages: 83 - 86
Hyperreactivity of Platelets to Serotonin (5-Hydroxytryptamine) in Patients with Cardiovascular Diseases Jean De CréeVera RoelsHerman Verhaegen Short Communication 18 October 2012 Pages: 87 - 91
Effects of Long Term Oral Administration of Ketanserin and Trichlormethiazide on Blood Pressure in Stroke-Prone Spontaneously Hypertensive Rats Masaru MinamiNaoya HamaueHideya Saito Short Communication 18 October 2012 Pages: 92 - 96
Inhibitory Effect of Ketanserin on Sympathetic Nerve Activity in Rats Mitsuhiro YoshiokaMatsumoto MachikoHideya Saito Short Communication 18 October 2012 Pages: 97 - 101
Contribution of Serotonergic Systems to Maintenance of Blood Pressure in Anaesthetised Normotensive Wistar Kyoto and Conscious Spontaneously Hypertensive Rats B. -G. SchulzG. SchröderG. Stock Short Communication 18 October 2012 Pages: 102 - 104
A New Selective Antagonist of Vascular Serotonin Receptors Lowers Blood Pressure in Spontaneously Hypertensive Rats P. SalvatiF. VaghiG. Bianchi Short Communication 18 October 2012 Pages: 105 - 109
Antihypertensive Effect of Long Term Ketanserin in Elderly Essential Hypertensive Patients R. A. SánchezF. OteroE. J. Marcó Short Communication 18 October 2012 Pages: 110 - 113
Pharmacokinetic Properties of Ketanserin in Man with Normal or Reduced Renal Function after Single Dose Oral Administration Kaoru OnoyamaN. OuchiS. Koboyashi Short Communication 18 October 2012 Pages: 114 - 114
Haemodynamic Changes Associated with Long Term Antihypertensive Therapy with Ketanserin Hiroshi NodaMasaaki IsakaToshiro Fujita Short Communication 18 October 2012 Pages: 115 - 119
Effects of Ketanserin on Systemic and Regional Haemodynamics in Patients with Essential Hypertension Yasushi ItoMasaaki IsakaToshiro Fujita Short Communication 18 October 2012 Pages: 120 - 122
Influence of Ketanserin on Glucose and Lipid Metabolism in Diabetic Patients with Hypertension H. U. JankaH. MehnertK. -U. Seiler Short Communication 18 October 2012 Pages: 123 - 125
Effect of Ketanserin on Lipoproteins in Patients with Essential Hypertension K. ArakawaJun SasakiH. Doi Short Communication 18 October 2012 Pages: 126 - 129
Comparative Trial of Ketanserin or Bendrofluazide as Add-On Therapy in Hypertensive Patients Uncontrolled on a β-Blocker Alone K. KorliparaSusan E. GouldT. C. Chandler Short Communication 18 October 2012 Pages: 130 - 134
Ketanserin, an Effective Third-Line Agent in Primary Hypertension J. J. MurphyP. H. WhincupR. G. Wilcox Short Communication 18 October 2012 Pages: 135 - 139
Comparative Study of Ketanserin and Hydrochlorothiazide in Essential Hypertension I. W. BaymanSusan E. GouldThe Janssen Research Group Short Communication 18 October 2012 Pages: 140 - 143
Comparison of Ketanserin with Captopril in Older Hypertensives P. MeyerM. Safar Short Communication 18 October 2012 Pages: 144 - 147
Hypertensive Patients with Raynaud’s Phenomenon or Intermittent Claudication and Their Treatment with Ketanserin J. C. van Oene Short Communication 18 October 2012 Pages: 148 - 151
